S.892 - Opioid Addiction Prevention Act of 2017115th Congress (2017-2018)
|Sponsor:||Sen. Gillibrand, Kirsten E. [D-NY] (Introduced 04/07/2017)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 04/07/2017 Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.892 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (04/07/2017)
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.